Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 44, Issue 12

Issues

Effect of tibolone therapy on lipids and coagulation indices

Rose Daher / Hadi Al-Amin / Mona Beaini / Ihab Usta
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2006.269

References

  • 1.

    Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419–27.Google Scholar

  • 2.

    Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002;288:321–33.Google Scholar

  • 3.

    Bjarnason NH, Bjarnason K, Haarbo J, Bennink HJ, Christiansen C. Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab 1997; 82:1752–6.CrossrefGoogle Scholar

  • 4.

    Macart M, Koffi A, Henocque G, Mathieu JF, Guilbaud JC. Optimized microturbidimetric assay for firbinogen. Clin Chem 1989; 35:211–4.Google Scholar

  • 5.

    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecol Endocrinol 2004; 18:244–57.CrossrefGoogle Scholar

  • 6.

    Farish E, Barnes JF, Rolton HA, Spowart K, Fletcher CD, Hart DM. Effects of tibolone on lipoprotein(a) and HDL-C subfractions. Maturitas 1994; 20:215–9.CrossrefGoogle Scholar

  • 7.

    Malatyalioğlu E, Kökçü A, Yanik FF, Alper T. Effects of four different hormone replacement therapy regimens on certain cardiovascular risk factors. Turk J Med Sci 2000; 30:469–73.Google Scholar

  • 8.

    Jackson G. Tibolone and the cardiovascular system. Eur Heart J Suppl 2001; 3(Suppl M):M17–21.CrossrefGoogle Scholar

  • 9.

    Winkler UH, Altkemper R, Kwee B, Helmond FA, Coelingh Bennink HJ. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertil Steril 2000; 74:10–19.CrossrefGoogle Scholar

About the article

Corresponding author: Rose Daher, PhD, DABCC, FACB, Associate Professor of Medicine, Assistant Director of Chemistry, Department of Pathology and Laboratory Medicine, American University of Beirut, P.O. Box: 11-0236, Beirut, 1107-2020 Lebanon Phone: +961-1-350000 (5223), Fax: +961-1-370845,


Published Online: 2011-09-21

Published in Print: 2006-12-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 44, Issue 12, Pages 1498–1499, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.269.

Export Citation

©2006 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cristina Vassalle, Ettore Cicinelli, Stefano Lello, Antonella Mercuri, Debora Battaglia, and Silvia Maffei
Gynecological Endocrinology, 2011, Volume 27, Number 3, Page 163

Comments (0)

Please log in or register to comment.
Log in